Literature DB >> 11907357

Barrett's esophagus and achalasia.

Jin-Ping Guo1, Philip B Gilman, Rebecca M Thomas, Robert S Fisher, Henry P Parkman.   

Abstract

Two unusual cases of achalasia with endoscopic and histologic documentation of Barrett's esophagus are presented. One patient had Barrett's esophagus at the time of initial endoscopy for achalasia, before any treatment. The other patient developed specialized columnar epithelia in the esophagus after treatment with pneumatic dilation. Each patient had evidence of low-grade dysplasia. Including these two patients, 30 cases of Barrett's esophagus in patients with achalasia have been reported in the literature. In 73% (22 of 30) of the cases, Barrett's esophagus was detected after esophagomyotomy. In 20% (6 of 30) of the cases of achalasia and Barrett's esophagus, adenocarcinoma developed. The current two cases are unusual because Barrett's esophagus in achalasia generally develops from gastroesophageal reflux after esophagomyotomy. No other patients have been reported to develop Barrett's esophagus after pneumatic dilation alone. Patients with achalasia and Barrett's esophagus may be at a particularly high risk for developing dysplasia and adenocarcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 11907357     DOI: 10.1097/00004836-200204000-00011

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  Modern management of achalasia.

Authors:  Joel E Richter
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 2.  Update on the Diagnosis and Treatment of Achalasia.

Authors:  Wojciech Blonski; Samuel Slone; Joel E Richter
Journal:  Dysphagia       Date:  2022-05-18       Impact factor: 3.438

3.  Tailoring Therapy for Achalasia.

Authors:  Joel E Richter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-05

4.  Achalasia combined with esophageal cancer treated by concurrent chemoradiation therapy.

Authors:  Jun Chul Park; Yong Chan Lee; Sang Kyum Kim; Yu Jin Kim; Sung Kwan Shin; Sang Kil Lee; Hoguen Kim; Choong Bai Kim
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

5.  Postoperative Gastroesophageal Reflux After Laparoscopic Heller-Dor for Achalasia: True Incidence with an Objective Evaluation.

Authors:  Renato Salvador; Elisa Pesenti; Laura Gobbi; Giovanni Capovilla; Lorenzo Spadotto; Guerrino Voltarel; Francesco Cavallin; Loredana Nicoletti; Michele Valmasoni; Alberto Ruol; Stefano Merigliano; Mario Costantini
Journal:  J Gastrointest Surg       Date:  2016-06-30       Impact factor: 3.452

6.  Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.

Authors:  I Leeuwenburgh; P Scholten; T J Caljé; R J Vaessen; H W Tilanus; B E Hansen; E J Kuipers
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

Review 7.  Gastroesophageal Reflux Disease Might Induce Certain-Supposedly Adaptive-Changes in the Esophagus: A Hypothesis.

Authors:  Laura Bognár; András Vereczkei; András Papp; Gábor Jancsó; Örs Péter Horváth
Journal:  Dig Dis Sci       Date:  2018-07-11       Impact factor: 3.199

Review 8.  The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders.

Authors:  Francisco Tustumi; Jorge Henrique Bento de Sousa; Nicolas Medeiros Dornelas; Guilherme Maganha Rosa; Milton Steinman; Edno Tales Bianchi
Journal:  Med Sci (Basel)       Date:  2021-05-21

9.  Barrett's Oesophagus in an Achalasia Patient: Immunological Analysis and Comparison with a Group of Achalasia Patients.

Authors:  Samuel Torres-Landa; Janette Furuzawa-Carballeda; Enrique Coss-Adame; Miguel A Valdovinos; Edgar Alejandro-Medrano; Bárbara Ramos-Ávalos; Braulio Martínez-Benítez; Gonzalo Torres-Villalobos
Journal:  Case Rep Gastrointest Med       Date:  2016-09-26

10.  Achalasia following reflux disease: coincidence, consequence, or accommodation? An experience-based literature review.

Authors:  András Vereczkei; Laura Bognár; András Papp; Örs Péter Horváth
Journal:  Ther Clin Risk Manag       Date:  2017-12-29       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.